{"id":5111,"date":"2020-01-17T00:00:00","date_gmt":"2020-01-16T23:00:00","guid":{"rendered":"https:\/\/www.boehmert.de\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/"},"modified":"2022-08-02T17:12:46","modified_gmt":"2022-08-02T15:12:46","slug":"breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe","status":"publish","type":"post","link":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/","title":{"rendered":"Breaking: Broad Institutes CRISPR\/Cas9 Gene Editing patent finally revoked in Europe!"},"content":{"rendered":"<p>Yesterday, on January 16, 2020, the Board of Appeal in the opposition proceedings for revocation of the European patent No. EP 2 771 468, Broad Institutes initial patent claiming the gene editing approach in mammalian cells, has been revoked after 4 days of intensive proceedings at the European Patent Office (EPO) in Munich.<\/p>\n<p>Nine opponents had filed oppositions against the grant of the CRISPR patent, and the appeal proceedings had been initiated by the Broad Institute after a first instance decision to revoke the patent in its entirety as not novel because of a defect in the priority claim. The Technical Board of Appeal yesterday confirmed the first instance decision surprisingly; since the day before it had indicated its preliminary inclination to refer this case to the Enlarged Board of Appeal \u2013 the highest judicial body at the EPO. However, after yesterday\u2019s pleadings, apparently, the Technical Board changed its mind in a dramatic reversal of its previous announcements and dismissed the appeal. The patent remains revoked; the decision is final and cannot be contested for substantive reasons.<\/p>\n<p>While a disaster for the Broad Institutes CRISPR patent portfolio, the decision will render development and business in the gene editing field in Europe possibly easier. From a legal point of view, the decision again confirms the long standing practice of the EPO to demand identity between the applicant of the priority application and the subsequent application, or an impeccable chain of transfer of the original priority rights to the non-identical applicant of the later application. This underlines the complexity and importance of establishing a correct priority claim under European law.<\/p>","protected":false},"excerpt":{"rendered":"<p>Yesterday, on January 16, 2020, the Board of Appeal in the opposition proceedings for revocation of the European patent No. EP 2 771 468, Broad Institutes initial patent claiming the gene editing approach in mammalian cells, has been revoked after&#8230;<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[63],"tags":[],"legal_areas":[],"class_list":["post-5111","post","type-post","status-publish","format-standard","hentry","category-ip-update-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Broad Institutes CRISPR\/Cas9 Gene Editing patent<\/title>\n<meta name=\"description\" content=\"Board of Appeal: Broad Institutes CRISPR\/Cas9 genome editing patent finally revoked in Europe on January 16, 2020!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Broad Institutes CRISPR\/Cas9 Gene Editing patent\" \/>\n<meta property=\"og:description\" content=\"Board of Appeal: Broad Institutes CRISPR\/Cas9 genome editing patent finally revoked in Europe on January 16, 2020!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"BOEHMERT &amp; BOEHMERT\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-16T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-02T15:12:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.boehmert.de\/wp-content\/uploads\/2026\/07\/boehmert-und-boehmert.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Petra Hettenkofer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Petra Hettenkofer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/\"},\"author\":{\"name\":\"Petra Hettenkofer\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/person\\\/e46018db6ce9c808bc0f35de4a8cec19\"},\"headline\":\"Breaking: Broad Institutes CRISPR\\\/Cas9 Gene Editing patent finally revoked in Europe!\",\"datePublished\":\"2020-01-16T23:00:00+00:00\",\"dateModified\":\"2022-08-02T15:12:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/\"},\"wordCount\":274,\"publisher\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#organization\"},\"articleSection\":[\"IP-Update\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/\",\"name\":\"Broad Institutes CRISPR\\\/Cas9 Gene Editing patent\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#website\"},\"datePublished\":\"2020-01-16T23:00:00+00:00\",\"dateModified\":\"2022-08-02T15:12:46+00:00\",\"description\":\"Board of Appeal: Broad Institutes CRISPR\\\/Cas9 genome editing patent finally revoked in Europe on January 16, 2020!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breaking: Broad Institutes CRISPR\\\/Cas9 Gene Editing patent finally revoked in Europe!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/\",\"name\":\"BOEHMERT & BOEHMERT\",\"description\":\"Intellectual property law firm\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#organization\",\"name\":\"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB\",\"alternateName\":\"BOEHMERT & BOEHMERT\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Logo-boehmert.webp\",\"contentUrl\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Logo-boehmert.webp\",\"width\":696,\"height\":172,\"caption\":\"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/de.linkedin.com\\\/company\\\/boehmert-&-boehmert\",\"https:\\\/\\\/www.xing.com\\\/pages\\\/boehmert-boehmertanwaltssozietat\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/person\\\/e46018db6ce9c808bc0f35de4a8cec19\",\"name\":\"Petra Hettenkofer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Broad Institutes CRISPR\/Cas9 Gene Editing patent","description":"Board of Appeal: Broad Institutes CRISPR\/Cas9 genome editing patent finally revoked in Europe on January 16, 2020!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/","og_locale":"en_US","og_type":"article","og_title":"Broad Institutes CRISPR\/Cas9 Gene Editing patent","og_description":"Board of Appeal: Broad Institutes CRISPR\/Cas9 genome editing patent finally revoked in Europe on January 16, 2020!","og_url":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/","og_site_name":"BOEHMERT &amp; BOEHMERT","article_published_time":"2020-01-16T23:00:00+00:00","article_modified_time":"2022-08-02T15:12:46+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2026\/07\/boehmert-und-boehmert.webp","type":"image\/webp"}],"author":"Petra Hettenkofer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Petra Hettenkofer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/#article","isPartOf":{"@id":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/"},"author":{"name":"Petra Hettenkofer","@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/person\/e46018db6ce9c808bc0f35de4a8cec19"},"headline":"Breaking: Broad Institutes CRISPR\/Cas9 Gene Editing patent finally revoked in Europe!","datePublished":"2020-01-16T23:00:00+00:00","dateModified":"2022-08-02T15:12:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/"},"wordCount":274,"publisher":{"@id":"https:\/\/www.boehmert.de\/en\/#organization"},"articleSection":["IP-Update"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/","url":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/","name":"Broad Institutes CRISPR\/Cas9 Gene Editing patent","isPartOf":{"@id":"https:\/\/www.boehmert.de\/en\/#website"},"datePublished":"2020-01-16T23:00:00+00:00","dateModified":"2022-08-02T15:12:46+00:00","description":"Board of Appeal: Broad Institutes CRISPR\/Cas9 genome editing patent finally revoked in Europe on January 16, 2020!","breadcrumb":{"@id":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.boehmert.de\/en\/breaking-broad-institutes-crispr-cas9-gene-editing-patent-finally-revoked-in-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.boehmert.de\/en\/"},{"@type":"ListItem","position":2,"name":"Breaking: Broad Institutes CRISPR\/Cas9 Gene Editing patent finally revoked in Europe!"}]},{"@type":"WebSite","@id":"https:\/\/www.boehmert.de\/en\/#website","url":"https:\/\/www.boehmert.de\/en\/","name":"BOEHMERT & BOEHMERT","description":"Intellectual property law firm","publisher":{"@id":"https:\/\/www.boehmert.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.boehmert.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.boehmert.de\/en\/#organization","name":"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB","alternateName":"BOEHMERT & BOEHMERT","url":"https:\/\/www.boehmert.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2026\/07\/Logo-boehmert.webp","contentUrl":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2026\/07\/Logo-boehmert.webp","width":696,"height":172,"caption":"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB"},"image":{"@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/de.linkedin.com\/company\/boehmert-&-boehmert","https:\/\/www.xing.com\/pages\/boehmert-boehmertanwaltssozietat"]},{"@type":"Person","@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/person\/e46018db6ce9c808bc0f35de4a8cec19","name":"Petra Hettenkofer"}]}},"_links":{"self":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/posts\/5111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/comments?post=5111"}],"version-history":[{"count":0,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/posts\/5111\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/media?parent=5111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/categories?post=5111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/tags?post=5111"},{"taxonomy":"legal_areas","embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/legal_areas?post=5111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}